Morio, Reona
Imamura, Michio
Kawakami, Yoshiiku
Morio, Kei
Kobayashi, Tomoki
Yokoyama, Satoe
Kimura, Yuki
Nagaoki, Yuko
Kawaoka, Tomokazu
Tsuge, Masataka
Hiramatsu, Akira
Nelson Hayes, C.
Aikata, Hiroshi
Takahashi, Shoichi
Miki, Daiki
Ochi, Hidenori
Mori, Nami
Takaki, Shintaro
Tsuji, Keiji
Chayama, Kazuaki
Funding for this research was provided by:
AMED (15fk0210001h0002)
Article History
Received: 29 May 2016
Accepted: 25 August 2016
First Online: 8 September 2016
Compliance with ethical standards
:
: Kazuaki Chayama has received honoraria from MSD, Bristol-Myers Squibb, Gilead Sciences, and AbbVie and research funding from Dainippon Sumitomo Pharma, TORAY, Eisai, Otsuka Pharma, Mitsubishi Tanabe Pharma, Daiichi Sankyo, and Bristol-Myers Squibb. Michio Imamura has received honoraria and research funding from Bristol-Myers Squibb. Masataka Tsuge has received research funding from Bristol-Myers Squibb.
: This research is partially supported by research funding from the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (Grant Number 15fk0210001h0002). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.